Manual Merck

Please confirm that you are not located inside the Russian Federation

honeypot link

Rebecca Dezube, MD, MHS

Especialidades y experiencia

  • Pulmonary Medicine, Critical Care Medicine

Afiliaciones

Educación

  • Medical School: Vanderbilt University School of Medicine, Nashville, TN
  • Residency: Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
  • Fellowship: Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
  • Master of Health Science: Clinical Investigation, Johns Hopkins University School of Medicine, Baltimore, MD

  • American Board of Internal Medicine – Pulmonary Disease
  • American Board of Internal Medicine – Critical Care Medicine
  • American Board of Internal Medicine – Internal Medicine

Seleccionar premios, logros y publicaciones

  • Eberlein M, Arnaoutakis GJ, Yarmus L, Feller-Kopman D, Dezube R, et al: The effect of lung size mismatch on complications and resource utilization after bilateral lung transplantation. J Heart Lung Transplant 31(5):492-500, 2012.
  • Dezube R, Arnaoutakis GJ, Reed RM, et al: The effect of lung-size mismatch on mechanical ventilation tidal volumes after bilateral lung transplantation. Interact Cardiovasc Thorac Surg 16(3):275-281, 2013.
  • Desai SV, Feldman L, Brown L, Dezube R, et al: Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. JAMA Intern Med
  • Jennings MT, Dezube R, Paranjape S, et al: An observational study of outcomes and tolerances in patients with cystic fibrosis initiated on lumacaftor/ivacaftor. Ann Am Thorac Soc 14(11):1662-1666, 2017.
  • Dezube R, Jennings MT, Rykiel M, et al: Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J Cyst Fibros 18(3):357-363, 2019.
  • Akshintala VS, Kamal A, Faghih M, Cutting GR, Cebotaru L, West NE, Jennings MT, Dezube R, et al: Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient
  • Safirstein J, Grant JJ, Clausen E, Savant D, Dezube R, Hong G. Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis. J Cyst Fibros S1569-1993(20)30806-7, 2020.
  • Montemayor K, Psoter KJ, Lechtzin N, Carson SW, Merlo CA, Dezube RH, et al: Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations. J Cyst Fibros S1569-1993(21)00163-6, 2021.